Please use this identifier to cite or link to this item:
http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3251Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Faircloth, Glynn | - |
| dc.creator | Avilés Marín, Pablo | - |
| dc.creator | Lepage, Doreen | - |
| dc.creator | San Miguel, Jesús F. | - |
| dc.creator | Pandiella, Atanasio | - |
| dc.date | 2008-03-18T16:38:49Z | - |
| dc.date | 2008-03-18T16:38:49Z | - |
| dc.date | 2007-09-07 | - |
| dc.date.accessioned | 2017-01-31T01:00:48Z | - |
| dc.date.available | 2017-01-31T01:00:48Z | - |
| dc.identifier | International Publication Number: WO 2007/101235 A2 | - |
| dc.identifier | http://hdl.handle.net/10261/3251 | - |
| dc.identifier.uri | http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3251 | - |
| dc.description | Filing Date: 2007-02-28.- Priority Data: US 60/813,606 (2006-02-28). | - |
| dc.description | The present invention relates to combinations of aplidine or aplidine analogues with other antitumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma. | - |
| dc.description | Pharma Mar, S.A.U. | - |
| dc.description | Peer reviewed | - |
| dc.format | 4545663 bytes | - |
| dc.format | application/pdf | - |
| dc.language | eng | - |
| dc.rights | openAccess | - |
| dc.subject | Cancer treatment | - |
| dc.subject | Antitumoral agents | - |
| dc.subject | Aplidine | - |
| dc.title | Improved antitumoral treatments | - |
| dc.type | Patente | - |
| Appears in Collections: | Digital Csic | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.